On the other hand, variation in the levels of MIF and MIP-1β in metastatic CRC assign prognostic nature to these factors, while the association of MDC, IL-7, MIF, IL-21, and TNF-α with tolerance to therapy can be instrumental towards tailored therapy of CRC. The gene discussed is CCL4; the disease is colorectal carcinoma.